The United States has issued a patent to the French company protecting its porous ceramic implant loaded with active ingredients. The stock takes off on the stock market!
I.Ceram wins the timpani | Photo credits: I.Ceram
A fanfare weekend for I.Ceram. The title of this small medtech, specializing in orthopedic implants and ceramic implants loaded with antibiotics, soars by 71.4%, to 18 euros. The Limogeaude company has just taken a new step in its development, by obtaining a patent in the United States for its porous ceramic sternal implant loaded with active ingredient, in particular antibiotics. The porous structure of the ceramic, close to that of the bone, allows rapid reconstruction of the latter. ” CIera thus becomes the only company to be able to develop its porous alumina implants loaded with antibiotics on American soil for 20 years “, welcomes the company. Its technology is now protected against any manufacture, use or sale by another person or company across the Atlantic.
This patent is in addition to the one obtained in France at the end of 2016 and which concerned the unloaded porous ceramic sternal implant. ” These new implant technologies loaded with or without antibiotics have already been implanted in around ten countries and have made it possible to treat very complex infections such as mediastinitis, open septic fractures or even chronic infections. », emphasizes I.Ceram.
Invest